| |
Latest 10 SEC filings (by transaction date) for LGND within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,156 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,855 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -3,556 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -7,448 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,556 | $66.19 |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,156 | $68.51 |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,855 | $67.24 |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 7,448 | $46.20 |
Mar 6/24 | Mar 5/24 | Aryeh Jason | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,893 | |
Mar 6/24 | Mar 5/24 | Aryeh Jason | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,893 | $39.35 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for LGND within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,156 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,855 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -3,556 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -7,448 | |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,556 | $66.19 |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,156 | $68.51 |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,855 | $67.24 |
Mar 27/24 | Mar 25/24 | Davis Todd C | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 7,448 | $46.20 |
Mar 7/24 | Mar 5/24 | Sabba Stephen L | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,893 | |
Mar 7/24 | Mar 5/24 | Sabba Stephen L | Direct Ownership | Common Stock | S - Open market or private sale | -1,893 | $74.30 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |